UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Selective RET kinase inhibition for patients with RET-altered cancers

Annals of oncology, 2018-08, Vol.29 (8), p.1869-1876

2018

Volltextzugriff (PDF)

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study

The journal of clinical endocrinology and metabolism, 2006-03, Vol.91 (3), p.926-932

2006

Volltextzugriff (PDF)

Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1310-1316

2009

Volltextzugriff (PDF)

Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal

The journal of clinical endocrinology and metabolism, 2009-11, Vol.94 (11), p.4171-4179

2009

Volltextzugriff (PDF)

Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy

Annals of oncology, 2013-09, Vol.24 (9), p.2256-2261

2013

Volltextzugriff (PDF)

Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors

Archives of Dermatological Research, 2016-07, Vol.308 (5), p.357-365

2016

Volltextzugriff (PDF)

Adrenocortical carcinoma: The University of Texas M. D. Anderson Cancer Center experience update

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e15075-e15075

2010

Volltextzugriff (PDF)

Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes mellitus type

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4640-4640

2008

Volltextzugriff (PDF)

Recognized and unrecognized hyperglycemia in cancer inpatients

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.9079-9079

2007

Volltextzugriff (PDF)

Hyperglycemia, hypertriglyceridemia, and hypercholesterolemia in a phase I trial of the combination of an mTOR inhibitor and IGF-1 receptor inhibitor

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2597-2597

2010

Volltextzugriff (PDF)

Phase I trial of combination sorafenib and tipifarnib: The experience in advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5586-5586

2010

Volltextzugriff (PDF)

Phase II trial of sunitinib in medullary thyroid cancer (MTC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5504-5504

2010

Volltextzugriff (PDF)

Treatment (tx) with tyrosine kinase inhibitors (TKIs) for patients (pts) with differentiated thyroid cancer (DTC): The M. D. Anderson Cancer Center (MDACC) experience

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.6060-6060

2009

Volltextzugriff (PDF)

Phase I study combining an IGFR inhibitor (IMC-A12) and an mTOR inhibitor (temsirolimus) in patients with solid tumors or lymphoma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14535-e14535

2009

Volltextzugriff (PDF)

Hypocalcemia induced by bisphophonates in cancer patients with vitamin D deficiency

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19644-19644

2007

Volltextzugriff (PDF)

Survival of resectable pancreatic cancer patients with diabetes

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.4098-4098

2006

Volltextzugriff (PDF)

Hyperglycemia treatment is associated with longer length of hospital stay in colorectal cancer surgery patients

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.6133-6133

2006

Volltextzugriff (PDF)

Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma

Ophthalmic plastic and reconstructive surgery, 2003-11, Vol.19 (6), p.479-481

2003

Volltextzugriff (PDF)

Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma

Thyroid (New York, N.Y.), 2017-05, Vol.27 (5), p.672

2017

Volltextzugriff (PDF)

Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma

Thyroid (New York, N.Y.), 2017-01, Vol.27 (1), p.81

2017

Volltextzugriff (PDF)

Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma

Journal of the American College of Surgeons, 2017-05, Vol.224 (5), p.980-987

2017

Volltextzugriff (PDF)

Global Distribution of Measles Genotypes and Measles Molecular Epidemiology

The Journal of infectious diseases, 2011-07, Vol.204 (suppl_1), p.S514-S523

2011

Volltextzugriff (PDF)

Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in MEN1 Patients; A Clinico-Pathologic Challenge. The MD Anderson Case Series and Review of the Literature

International journal of surgery (London, England), 2016-07, Vol.31, p.10-16

2016

Volltextzugriff (PDF)

Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages

Surgery, 2018-11, Vol.164 (5), p.960-964

2018

Volltextzugriff (PDF)

Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer

Head & neck, 2017-07, Vol.39 (7), p.1291-1295

2017

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(47)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Female
(17)
Male
(16)
Middle Aged
(14)
Adult
(12)
Biological And Medical Sciences
(12)
Aged
(10)
Medical Sciences
(9)
Endocrinology & Metabolism
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Retrospective Studies
(8)
Infectious Diseases
(7)
Thyroid Neoplasms - Pathology
(7)
Microbiology
(6)
Surgery
(6)
Treatment Outcome
(6)
Endocrinopathies
(5)
Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective RET kinase inhibition for patients with RET-altered cancers

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study

Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer

Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal

Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy

Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors

Adrenocortical carcinoma: The University of Texas M. D. Anderson Cancer Center experience update

Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes mellitus type

Recognized and unrecognized hyperglycemia in cancer inpatients

Hyperglycemia, hypertriglyceridemia, and hypercholesterolemia in a phase I trial of the combination of an mTOR inhibitor and IGF-1 receptor inhibitor

Phase I trial of combination sorafenib and tipifarnib: The experience in advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC)

Phase II trial of sunitinib in medullary thyroid cancer (MTC)

Treatment (tx) with tyrosine kinase inhibitors (TKIs) for patients (pts) with differentiated thyroid cancer (DTC): The M. D. Anderson Cancer Center (MDACC) experience

Phase I study combining an IGFR inhibitor (IMC-A12) and an mTOR inhibitor (temsirolimus) in patients with solid tumors or lymphoma

Hypocalcemia induced by bisphophonates in cancer patients with vitamin D deficiency

Survival of resectable pancreatic cancer patients with diabetes

Hyperglycemia treatment is associated with longer length of hospital stay in colorectal cancer surgery patients

Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma

Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma

Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma

Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma

Global Distribution of Measles Genotypes and Measles Molecular Epidemiology

Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in MEN1 Patients; A Clinico-Pathologic Challenge. The MD Anderson Case Series and Review of the Literature

Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages

Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer

Suchergebnisse filtern